Healthcare

According to a market report by Lucintel, the future of the digital pathology market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The global digital pathology market is expected to reach an estimated $1,630.8 million by 2028 with a CAGR of 10.3% from 2023 to 2028. The major drivers for this market are increasing demand of digital pathology to enhance lab efficiency, growing incidence of cancer, and increasing investments in new digital pathology system by industry players across the globe.



In this market, scanners, software, and storage systems are the major segments of digital pathology market by product. Lucintel forecast that scanners will remain the larger segment over the forecast period because it helps in converting the images into digital form and also aids in viewing, analysing, managing, sharing, and storing them easily and efficiently.



Within this market, pharmaceutical & biotechnology companies are expected to remain the largest segment due increasing use of digital pathology in various applications, such as bio banking, biopharmaceutical studies, molecular assays, and in the development of individualised medicine.



North America will remain the largest region due to the increasing prevalence of cancer, growing adoption of digital imaging and presence of key market players in the region.  

Leica Biosystems, Koninklijke Philips N.V., Hamamatsu Photonics, F. Hoffmann-La Roche, 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Visiopharm A/S, Aiforia Technologies Oy, Akoya Biosciences, and Corista are the major suppliers in the global digital pathology market.  



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global digital pathology market by product, type, application, end use, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Digital Pathology Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global digital pathology market by product, type, application, end use, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the digital pathology market by product (scanners, software, and storage systems), type (human pathology and veterinary pathology), application (drug discovery, disease diagnosis, and training & education), end use (pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?